Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C V Hanson

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
HTLV-I and HTLV-II infection in UruguayG Muchinik, M B Bouzas, I Zapiola, et al.
AIDS (London, England)|August 1, 1995
Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodiesM P D'Souza, G Milman, J A Bradac, et al.
Transfusion|June 1, 1992
Detection of antibodies to human immunodeficiency virus type 2 (HIV-2) in blood donor sera using United States assay methods for anti-HIV type 1K Sazama, I K Kuramoto, P V Holland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2001
Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART)M K Morris, D A Katzenstein, D Israelski, et al.
Transfusion|July 14, 1998
Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with plateletsT H Lee, R R Stromberg, J W Heitman, et al.
Vox Sanguinis|January 1, 1994
Loss of red blood cell viability associated with limited thermal inactivation of extracellular HIV-1R R Stromberg, F A Kuypers, L Sawyer, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HTLV-I in ArgentinaM B Bouzas, G Picchio, G Muchinik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoproteinM K Gorny, J Y Xu, V Gianakakos, et al.
Journal of Virology|March 1, 1994
Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagatedL S Sawyer, M T Wrin, L Crawford-Miksza, et al.
Memorias Do Instituto Oswaldo Cruz|May 1, 1996
Immunoreactivity of Brazilian HIV isolates with different V3 motifsR M Hendry, C V Hanson, V Bongertz, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
HTLV-I and HTLV-II infection in UruguayG Muchinik, M B Bouzas, I Zapiola, et al.
AIDS (London, England)|August 1, 1995
Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodiesM P D'Souza, G Milman, J A Bradac, et al.
Transfusion|June 1, 1992
Detection of antibodies to human immunodeficiency virus type 2 (HIV-2) in blood donor sera using United States assay methods for anti-HIV type 1K Sazama, I K Kuramoto, P V Holland, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2001
Characterization of the HIV-1 specific humoral immune response during highly active antiretroviral therapy (HAART)M K Morris, D A Katzenstein, D Israelski, et al.
Transfusion|July 14, 1998
Distribution of HIV type 1 (HIV-1) in blood components: detection and significance of high levels of HIV-1 associated with plateletsT H Lee, R R Stromberg, J W Heitman, et al.
Vox Sanguinis|January 1, 1994
Loss of red blood cell viability associated with limited thermal inactivation of extracellular HIV-1R R Stromberg, F A Kuypers, L Sawyer, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
HTLV-I in ArgentinaM B Bouzas, G Picchio, G Muchinik, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoproteinM K Gorny, J Y Xu, V Gianakakos, et al.
Journal of Virology|March 1, 1994
Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagatedL S Sawyer, M T Wrin, L Crawford-Miksza, et al.
Memorias Do Instituto Oswaldo Cruz|May 1, 1996
Immunoreactivity of Brazilian HIV isolates with different V3 motifsR M Hendry, C V Hanson, V Bongertz, et al.
Pageof 6